Operative success is achieved regardless of ioPTH criterion used during focused parathyroidectomy for sporadic primary hyperparathyroidism

Am J Surg. 2023 Nov;226(5):604-608. doi: 10.1016/j.amjsurg.2023.06.031. Epub 2023 Jun 26.

Abstract

Background: Focused parathyroidectomy (F-PTX) guided by intraoperative parathormone (ioPTH) monitoring may result in higher operative failure rates from missed multiglandular disease (MGD) in patients with sporadic primary hyperparathyroidism (spHPT) when ioPTH levels do not reach normal range.

Methods: A retrospective review included 690 patients with spHPT who underwent F-PTX and ioPTH monitoring were divided into 2 groups: >50% ioPTH decrease to normal range, and >50% ioPTH decrease to above normal range. Operative success, recurrence, bilateral/unilateral neck exploration (BNE/UNE), MGD were evaluated.

Results: 533 patients demonstrated >50% ioPTH decrease to normal range, and 157 patients >50% ioPTH decrease to above normal range. There were no differences in operative success 99% vs. 97%, recurrence 2.5% vs. 5%, BNE 12% vs. 11%, UNE 4% vs. 5%, or MGD 4% vs. 4%, (p > 0.05) with 46 months mean follow-up.

Conclusions: There were no differences in operative success, failure, BNE, UNE or MGD regardless of ioPTH criterion used for F-PTX.

Keywords: Intraoperative PTH monitoring; Parathyroidectomy; Sporadic primary hyperparathyroidism; ioPTH criterion.

MeSH terms

  • Humans
  • Hyperparathyroidism, Primary* / surgery
  • Monitoring, Intraoperative
  • Parathyroid Hormone*
  • Parathyroidectomy
  • Retrospective Studies

Substances

  • Parathyroid Hormone